Fig. 3. AD80 is active against gatekeeper mutant RETV804M cells.

Slides:

Advertisements

Similar presentations

Fig. 2. Effects of AZD4785 on proliferation and MAPK pathway signaling in KRAS mutant and wild-type cancer cells in vitro. Effects of AZD4785 on proliferation.

Advertisements

Fig. 1. IL-6 is associated with resistance to EGFR TKIs and is induced by stress hormones. IL-6 is associated with resistance to EGFR TKIs and is induced.

Differentiation of AZD4785 from MAPK pathway inhibitors in vitro

Fig. 1. Potent and selective down-regulation of KRAS mRNA and protein by AZD4785 in vitro and in vivo. Potent and selective down-regulation of KRAS mRNA.

Fig. 5. Correlation between CD34+CD45RA−CD90+ cell dose, engraftment success, and onset of neutrophil/platelet recovery in nonhuman primates. Correlation.

Transfer of miR-223 during neutrophil-epithelial cell interactions

A FOXO3a-BIM cascade mediates sensitivity to PARP and MEK inhibition

Fig. 3. Structure of ALS-associated RNA binding proteins.

Fig. 3. Antimicrobial activity is detected in diverse strains of CoNS and not predictable at the species level. Antimicrobial activity is detected in diverse.

Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.

β-ARs signal cooperatively with mutant EGFR and inactivate LKB1

Fig. 4. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive and HBeAg-negative chimpanzees. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive.

Fig. 6. Treatment with a DLK inhibitor is neuroprotective and reverses stress-induced gene expression changes. Treatment with a DLK inhibitor is neuroprotective.

Fig. 4. Functional annotation of VUS in EGFR.

Fig. 1. Schematic representation of the MANO method.

Fig. 2. Mutant KRAS mediates resistance to PARPi and sensitivity to PARPi and MEKi Mutant KRAS mediates resistance to PARPi and sensitivity to PARPi and.

Fig. 3. A circadian rhythm in fibroblast wound-healing response.

PVSRIPO-mediated APC activation occurs in immunosuppressive conditions

MRSA virulence proteins cause LMC death and diminished CLV function

A functional proteomics platform to reveal the sequence determinants of lysine methyltransferase substrate selectivity by Evan M. Cornett, Bradley M. Dickson,

Fig. 2. GPC3 expression in normal and tumor tissues.

Fig. 5. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic mice. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic.

Fig. 5 A competent Fc is required for the antitumor immune response.

Fig. 1 Chemical inactivation of BPL kills Mtb and prevents growth in mouse macrophages. Chemical inactivation of BPL kills Mtb and prevents growth in mouse.

Fig. 4. In vivo analysis of slpA mutant in the Syrian Golden hamster.

Fig. 4. Antitumor efficacy of ERY974 against various cancer types.

Fig. 5. Toxin production and release in vitro.

Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.

Fig. 2. Effects of SFN in mouse hepatocytes and in rat models of diet-induced glucose intolerance. Effects of SFN in mouse hepatocytes and in rat models.

Type 1 immunity drives metabolic disease but protects against NAFLD

Effect of HUWE1 on MYC and MIZ1 complexes Immunoblot documenting levels of MYC and MIZ1 upon HUWE1 overexpression. Effect of HUWE1 on MYC and MIZ1 complexes.

Fig. 4. MATE1 transcription in RCC.

Fig. 2. Best model fits. Best model fits. Illustration of the best model fits for the (A) basic, (B) continuous, and (C) cluster models. See Table 1 and.

Fig. 4. Actin polymerization rhythms are required for circadian regulation of adhesion and wound-healing efficacy by fibroblasts. Actin polymerization.

Fig. 7 BRD0705 impairs colony formation in AML cell lines and patient cells and shows in vivo efficacy in multiple AML mouse models. BRD0705 impairs colony.

Fig. 4. Perampanel ameliorates behavioral deficits in mice expressing the Thorase variants. Perampanel ameliorates behavioral deficits in mice expressing.

Fig. 6. FGFR1 and CCND1 amplification–mediated resistance to estrogen deprivation is therapeutically actionable. FGFR1 and CCND1 amplification–mediated.

Antiproliferative effects of JQ-EZ-05 on VHL−/− ccRCC are on-target

Workflow of a sample-to-answer AST performed in less than 30 min

Fig. 1. Map showing the study catchment area in the East of England.

Fig. 7. ApoMSCs exert immunosuppressive activity in GvHD and elicit IDO in engulfing recipient phagocytes. ApoMSCs exert immunosuppressive activity in.

Fig. 3. β-AR signaling induces IL-6 in NSCLC cells via activation of PKC and CREB. β-AR signaling induces IL-6 in NSCLC cells via activation of PKC and.

Fig. 7. Inhibitory mechanisms of C12G6.

Fig. 2 Fas controls IL-1RA–sEV secretion in murine MSCs.

Fig. 1 BX795 suppresses HSV-1 infection.

Fig. 4 Effect of LRRK2 mutations on protein kinase activity and GTPase activity. Effect of LRRK2 mutations on protein kinase activity and GTPase activity.

Fig. 1. Thorase variants show defects in Thorase oligomer and GluA2-GRIP1 complex disassembly. Thorase variants show defects in Thorase oligomer and GluA2-GRIP1.

Fig. 5. Nutlin-3 treatment rescues the proliferation and differentiation of NPCs in vitro. Nutlin-3 treatment rescues the proliferation and differentiation.

KIF1Bβ promotes DHX9 nuclear localization.

Fig. 1 A single amino acid difference in the ATP-binding domain of GSK3α and GSK3β results in structural and topological differences. A single amino acid.

Fig. 2 Analysis of CLL lymph nodes.

Fig. 1 Effect of preinfection β7Hi CD45RA−CD4+ T cell frequency on HIV acquisition risk in CAPRISA 004 study. Effect of preinfection β7Hi CD45RA−CD4+ T.

PAAND is driven by local inflammasome activation and IL-1β production

Fig. 3. TKI sensitivity assessed by the MANO method.

Fig. 4. The effect of single-dose rozanolixizumab on the concentration of IgG subtypes in healthy subjects. The effect of single-dose rozanolixizumab on.

Fig. 2. Exposure of both TCR and CAR antigens diminishes efficacy of CAR8 but not CAR4 cells. Exposure of both TCR and CAR antigens diminishes efficacy.

CD facilitates RCT in vivo and promotes urinary cholesterol excretion

Fig. 3. HECTD2 contains a naturally occurring polymorphism at A19, which mislocalizes to the cytosol. HECTD2 contains a naturally occurring polymorphism.

Fig. 1. VHL−/− ccRCC cells exhibit altered H3K27 modifications and increased dependence on EZH1. VHL−/− ccRCC cells exhibit altered H3K27 modifications.

Fig. 5 BRD0705 induces differentiation in AML cell lines and primary patient samples through GSK3α-selective inhibition. BRD0705 induces differentiation.

Fig. 1 LB100 and LB102 specifically inhibit PP2A phosphatase activity and the growth of BCR-ABL+ cells. LB100 and LB102 specifically inhibit PP2A phosphatase.

Fig. 4. Clearance of 12-mer-1 from a nonhuman primate model.

Fig. 4 ALRN-6924 inhibits cellular proliferation and clonogenic capacity, and induces cell cycle arrest and apoptosis in AML cell lines. ALRN-6924 inhibits.

Fig. 3. Phenotypic characterization of FM2.5.

Fig. 6. Effect of SAHA and ML on histone acetylation, BAX, and p21CDKN1A expression.PANC-1 and BxPC-3 cells were incubated for 48 hours with 5 µM.

Degradation of the COPI proteins Ret1 and Sec21 by the AID system.

PKM2 is tyrosine phosphorylated and inhibited by FGFR1 in cancer cells with oncogenic or overexpressed FGFR1. PKM2 is tyrosine phosphorylated and inhibited.

Fig. 3. AD80 is active against gatekeeper mutant RETV804M cells.

Pdcd4 expression inhibits AP-1 transactivation.

Fig. 5 C9orf72 knockdown disrupts autophagy induction.

Presentation transcript:

Fig. 3. AD80 is active against gatekeeper mutant RETV804M cells. AD80 is active against gatekeeper mutant RETV804M cells. (A) Optimized structures after extensive MD refinement followed by ALPB optimization. (i) RETwt/AD80 after 102 ns, (ii) RETwt/AD57 after 202 ns (92 ns from RETwt/AD80 simulation followed by 110 ns from TI-MD), and (iii) RETV804M/AD80 after 107 ns (side view). The DFG motif is shown in violet. Distances from the center of central phenyl to Val804-C(wt), Ile788-C(wt), and Met804-S(V804M) are 4.77, 3.90, and 4.29 Å, respectively. Dashed lines indicate the H-bond between the bound ligands and aspartate of the DFG motif. (B) Heat map of mean 50% growth inhibition (GI50) values (n ≥ 3) of Ba/F3 cells expressing CCDC6-RETV804M or KIF5B-RETV804M after 72 hours of treatment, as assessed for various inhibitors. (C) Immunoblotting of AD80-, cabozantinib-, or vandetanib-treated (4 hours) KIF5B-RETV804M Ba/F3 cells. (D) Immunoblotting of Ba/F3 cells expressing CCDC6-RET-RETwt or CCDC6-RETV804M under AD80 or vandetanib treatment (4 hours). wt, wild type. (E) Calculated Michaelis constant (Km) values of ATP binding to RETwt or RETV804M from three independent experiments. ***P < 0.001, n = 3. Dennis Plenker et al., Sci Transl Med 2017;9:eaah6144 Published by AAAS